| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.26B | 25.54B | 23.38B | 21.61B | 22.27B | 19.12B |
| Gross Profit | 6.28B | 6.08B | 4.94B | 3.65B | 4.56B | 3.17B |
| EBITDA | 5.11B | 5.04B | 4.20B | 3.32B | 4.30B | 3.27B |
| Net Income | 1.91B | 1.55B | 1.93B | 594.95M | 985.25M | 613.59M |
Balance Sheet | ||||||
| Total Assets | 36.06B | 37.04B | 36.53B | 34.24B | 34.67B | 35.97B |
| Cash, Cash Equivalents and Short-Term Investments | 5.23B | 5.96B | 5.84B | 4.74B | 5.55B | 5.38B |
| Total Debt | 431.54M | 2.12B | 1.88B | 2.67B | 3.41B | 6.27B |
| Total Liabilities | 5.13B | 6.07B | 6.39B | 6.37B | 7.31B | 10.23B |
| Stockholders Equity | 30.40B | 30.44B | 29.63B | 27.39B | 26.92B | 25.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.28B | 2.73B | 1.09B | 3.45B | 3.43B |
| Operating Cash Flow | 0.00 | 2.89B | 4.23B | 2.69B | 3.95B | 4.09B |
| Investing Cash Flow | 0.00 | -2.65B | -1.58B | -1.59B | -500.26M | -656.84M |
| Financing Cash Flow | 0.00 | -846.50M | -1.28B | -1.19B | -3.46B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥22.30B | 9.59 | ― | 2.86% | 19.42% | 74.63% | |
75 Outperform | ¥14.60B | 4.37 | ― | 3.90% | -1.72% | 168.62% | |
71 Outperform | ¥22.52B | 11.42 | ― | 2.70% | -8.63% | -55.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥22.82B | -3.57 | ― | 3.19% | -8.99% | -62.26% | |
54 Neutral | ¥15.63B | -5.44 | ― | 2.45% | -2.67% | 33.63% | |
51 Neutral | ¥32.17B | 130.91 | ― | 2.45% | 4.93% | ― |